Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 27 | $12,897,789 |
Sells | 235 | $31,547,064 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 03 Jan 2023 | Purchase | 141,646 | 7.5047 | 1,063,011 | I |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 27 Dec 2022 | Purchase | 145,652 | 7.2392 | 1,054,404 | I |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | BURRELL TERRY-ANN | Director | 12 Jul 2023 | Sale | 78,071 | 12.1465 | 948,289 | D |
27 Feb 2023 16:06 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 24 Feb 2023 | Purchase | 109,118 | 7.639 | 833,552 | I |
04 Aug 2023 17:51 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Aug 2023 | Sale | 60,955 | 13.0171 | 793,457 | D |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 23 Dec 2022 | Purchase | 100,378 | 7.5158 | 754,421 | I |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 30 Dec 2022 | Purchase | 99,754 | 7.5548 | 753,622 | I |
22 Feb 2023 16:07 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 21 Feb 2023 | Purchase | 94,418 | 7.7435 | 731,126 | I |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 04 Jan 2023 | Purchase | 91,892 | 7.8013 | 716,877 | I |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 29 Dec 2022 | Purchase | 84,622 | 7.714 | 652,774 | I |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 05 Jan 2023 | Purchase | 80,035 | 7.3787 | 590,554 | I |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 09 Jan 2023 | Purchase | 76,046 | 7.638 | 580,839 | I |
10 Mar 2023 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 08 Mar 2023 | Sale | 70,890 | 8.096 | 573,925 | D |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 10 Jan 2023 | Purchase | 69,518 | 7.7224 | 536,846 | I |
03 Mar 2023 16:09 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 02 Mar 2023 | Purchase | 66,822 | 7.8171 | 522,354 | I |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 28 Dec 2022 | Purchase | 71,299 | 7.1796 | 511,898 | I |
09 Jun 2023 17:12 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 07 Jun 2023 | Sale | 56,436 | 9.0511 | 510,808 | D |
13 Jan 2023 16:19 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 06 Jan 2023 | Purchase | 68,953 | 7.4052 | 510,611 | I |
21 Feb 2023 16:07 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 17 Feb 2023 | Purchase | 63,382 | 7.7149 | 488,986 | I |
07 Jun 2024 16:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Jun 2024 | Sale | 50,000 | 9 | 450,000 | D |
08 Dec 2023 17:22 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Dec 2023 | Sale | 59,829 | 7.4946 | 448,394 | D |
09 Feb 2024 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 07 Feb 2024 | Sale | 48,272 | 9.2182 | 444,981 | D |
06 Oct 2023 18:12 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 04 Oct 2023 | Sale | 59,794 | 7.2085 | 431,025 | D |
08 Mar 2024 19:08 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Mar 2024 | Sale | 36,319 | 11.8583 | 430,682 | D |
07 Jun 2024 16:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 05 Jun 2024 | Sale | 50,000 | 8.42 | 421,000 | D |
19 Jul 2023 19:01 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 18 Jul 2023 | Sale | 30,000 | 13.74 | 412,200 | D |
01 Apr 2024 18:40 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 28 Mar 2024 | Sale | 40,000 | 10.1 | 404,000 | D |
24 Feb 2023 16:08 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 23 Feb 2023 | Purchase | 51,864 | 7.7856 | 403,792 | I |
28 Feb 2023 16:14 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 27 Feb 2023 | Purchase | 52,500 | 7.69 | 403,725 | I |
23 Feb 2023 16:26 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 22 Feb 2023 | Purchase | 50,941 | 7.8329 | 399,016 | I |
02 Mar 2023 16:05 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 01 Mar 2023 | Purchase | 48,867 | 7.9416 | 388,082 | I |
03 May 2024 18:24 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 May 2024 | Sale | 50,000 | 7.73 | 386,500 | D |
11 Jan 2024 18:51 | RXRX | RECURSION PHARMACEUTICALS Inc | LI DEAN Y | Director | 09 Jan 2024 | Sale | 28,038 | 13.65 | 382,719 | I |
12 Jul 2024 18:54 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 10 Jul 2024 | Sale | 50,000 | 7.48 | 374,000 | D |
12 Jul 2024 18:54 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 11 Jul 2024 | Sale | 50,000 | 7.47 | 373,500 | D |
05 Apr 2024 17:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 04 Apr 2024 | Sale | 40,000 | 9.02 | 360,800 | D |
05 Apr 2024 17:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Apr 2024 | Sale | 40,000 | 8.84 | 353,600 | D |
19 Jul 2023 19:01 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 17 Jul 2023 | Sale | 30,000 | 11.72 | 351,600 | D |
17 Feb 2023 17:27 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 16 Feb 2023 | Purchase | 42,682 | 7.8966 | 337,043 | I |
19 Jul 2023 19:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 18 Jul 2023 | Sale | 24,500 | 13.6236 | 333,778 | D |
08 Sep 2023 17:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Sep 2023 | Sale | 33,765 | 8.7835 | 296,575 | D |
05 Jan 2024 20:03 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Jan 2024 | Sale | 30,853 | 9.4903 | 292,804 | D |
27 Jul 2023 18:31 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 26 Jul 2023 | Sale | 20,000 | 14.41 | 288,200 | D |
27 Jul 2023 18:31 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 25 Jul 2023 | Sale | 20,000 | 14.3 | 286,000 | D |
14 Mar 2024 19:28 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Mar 2024 | Sale | 25,000 | 11.0326 | 275,815 | D |
27 Jul 2023 18:30 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 25 Jul 2023 | Sale | 18,719 | 14.6089 | 273,464 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | BURRELL TERRY-ANN | Director | 12 Jul 2023 | Sale | 24,302 | 11.2501 | 273,400 | D |
07 Apr 2023 17:30 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Apr 2023 | Sale | 40,000 | 6.6418 | 265,672 | D |
14 Mar 2024 19:28 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 12 Mar 2024 | Sale | 25,000 | 10.455 | 261,375 | D |
18 Jan 2024 18:37 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 16 Jan 2024 | Sale | 25,000 | 10.4464 | 261,160 | D |
14 Feb 2023 16:10 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 13 Feb 2023 | Purchase | 32,474 | 7.9706 | 258,837 | I |
18 Jan 2024 18:37 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 17 Jan 2024 | Sale | 25,000 | 10.2539 | 256,348 | D |
01 Apr 2024 18:40 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 28 Mar 2024 | Sale | 25,000 | 10.1 | 252,500 | I |
15 Jun 2023 19:28 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 14 Jun 2023 | Sale | 25,000 | 10.0735 | 251,837 | D |
15 Feb 2024 18:00 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 14 Feb 2024 | Sale | 23,933 | 10.4335 | 249,705 | D |
15 Jun 2023 19:28 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Jun 2023 | Sale | 25,000 | 9.9323 | 248,308 | D |
14 Jul 2023 18:52 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 12 Jul 2023 | Sale | 17,227 | 14.344 | 247,104 | D |
15 Feb 2024 18:00 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Feb 2024 | Sale | 25,000 | 9.8624 | 246,560 | D |
03 May 2024 18:24 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 May 2024 | Sale | 28,704 | 8.47 | 243,123 | D |
21 Feb 2024 17:37 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 20 Feb 2024 | Sale | 19,745 | 12.3117 | 243,095 | D |
07 Mar 2024 18:53 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 05 Mar 2024 | Sale | 20,054 | 12.0577 | 241,805 | D |
17 Aug 2023 18:35 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 15 Aug 2023 | Sale | 25,000 | 9.2717 | 231,792 | D |
08 Mar 2024 19:08 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Mar 2024 | Sale | 20,000 | 11.5501 | 231,002 | I |
05 Apr 2024 17:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 04 Apr 2024 | Sale | 25,000 | 9.02 | 225,500 | I |
17 Aug 2023 18:35 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 16 Aug 2023 | Sale | 25,000 | 8.9007 | 222,518 | D |
05 Apr 2024 17:44 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Apr 2024 | Sale | 25,000 | 8.84 | 221,000 | I |
14 Sep 2023 18:26 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Sep 2023 | Sale | 25,000 | 8.6927 | 217,318 | D |
21 Mar 2024 17:38 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 19 Mar 2024 | Sale | 20,054 | 10.792 | 216,423 | D |
07 Oct 2022 19:19 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Oct 2022 | Sale | 18,500 | 11.6514 | 215,551 | D |
05 Jun 2023 18:29 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 01 Jun 2023 | Sale | 25,000 | 8.58 | 214,500 | D |
28 Dec 2023 17:48 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 26 Dec 2023 | Sale | 20,054 | 10.6285 | 213,144 | D |
09 Aug 2024 16:56 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 07 Aug 2024 | Sale | 30,000 | 7.1 | 213,000 | D |
25 Jan 2024 18:13 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 23 Jan 2024 | Sale | 20,054 | 10.5756 | 212,083 | D |
14 Sep 2023 18:26 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 12 Sep 2023 | Sale | 25,000 | 8.4253 | 210,632 | D |
16 May 2024 16:35 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 14 May 2024 | Sale | 20,054 | 10.1194 | 202,934 | D |
19 Jul 2023 19:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 19 Jul 2023 | Sale | 13,150 | 15.3626 | 202,018 | D |
07 Oct 2022 19:19 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Oct 2022 | Sale | 17,553 | 11.5033 | 201,917 | D |
18 Nov 2022 17:47 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 16 Nov 2022 | Sale | 17,770 | 11.1204 | 197,610 | D |
18 Jan 2024 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 16 Jan 2024 | Sale | 18,000 | 10.93 | 196,740 | D |
03 Nov 2023 18:14 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Nov 2023 | Sale | 37,177 | 5.1996 | 193,306 | D |
26 Jan 2023 16:11 | RXRX | RECURSION PHARMACEUTICALS Inc | MUBADALA INVESTMENT CO PJSC | 10% | 25 Jan 2023 | Purchase | 24,526 | 7.8801 | 193,267 | I |
18 Apr 2024 17:12 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 16 Apr 2024 | Sale | 25,000 | 7.6663 | 191,658 | D |
05 Jan 2024 20:03 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Jan 2024 | Sale | 20,000 | 9.512 | 190,240 | I |
11 Jan 2024 18:50 | RXRX | RECURSION PHARMACEUTICALS Inc | BORGESON BLAKE | Director | 09 Jan 2024 | Sale | 13,751 | 13.8117 | 189,925 | D |
14 Dec 2023 18:53 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 13 Dec 2023 | Sale | 25,000 | 7.5908 | 189,770 | D |
04 Nov 2022 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Nov 2022 | Sale | 18,500 | 10.1101 | 187,037 | D |
14 Dec 2023 18:53 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 12 Dec 2023 | Sale | 25,000 | 7.3947 | 184,868 | D |
18 Dec 2023 18:44 | RXRX | RECURSION PHARMACEUTICALS Inc | DAR ZAVAIN | Director | 14 Dec 2023 | Sale | 20,141 | 9 | 181,269 | D |
03 May 2024 18:24 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 May 2024 | Sale | 21,296 | 8.47 | 180,377 | D |
04 Nov 2022 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 03 Nov 2022 | Sale | 18,193 | 9.889 | 179,911 | D |
12 Oct 2023 18:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 10 Oct 2023 | Sale | 25,000 | 7.0705 | 176,762 | D |
08 Sep 2023 17:01 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 06 Sep 2023 | Sale | 20,000 | 8.8348 | 176,696 | I |
17 Nov 2022 18:46 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 17 Nov 2022 | Sale | 16,000 | 10.9626 | 175,402 | D |
18 Apr 2024 17:12 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 17 Apr 2024 | Sale | 23,124 | 7.583 | 175,349 | D |
03 Oct 2022 19:32 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 29 Sep 2022 | Sale | 15,936 | 10.8566 | 173,011 | D |
19 Dec 2023 19:22 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Dec 2023 | Sale | 18,000 | 9.6 | 172,800 | D |
02 Dec 2022 18:17 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 01 Dec 2022 | Sale | 18,500 | 9.2765 | 171,615 | D |
28 Oct 2022 18:07 | RXRX | RECURSION PHARMACEUTICALS Inc | LARSON TINA MARRIOTT | President and COO | 27 Oct 2022 | Sale | 16,000 | 10.7156 | 171,450 | D |
12 Oct 2023 18:07 | RXRX | RECURSION PHARMACEUTICALS Inc | SECORA MICHAEL | Chief Financial Officer | 11 Oct 2023 | Sale | 25,000 | 6.8525 | 171,312 | D |
03 Feb 2023 17:11 | RXRX | RECURSION PHARMACEUTICALS Inc | GIBSON CHRISTOPHER | Chief Executive Officer | 02 Feb 2023 | Sale | 18,500 | 9.2188 | 170,548 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)